ProfileGDS4718 / 1562815_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 14% 17% 11% 13% 16% 12% 23% 21% 14% 13% 12% 15% 14% 18% 19% 11% 11% 13% 11% 16% 14% 14% 10% 8% 10% 18% 17% 18% 23% 15% 18% 16% 12% 13% 10% 21% 12% 14% 10% 15% 13% 6% 19% 20% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.9506714
GSM549102patient 115, normal, homogenized [OPG study]4.0352617
GSM549104patient 119, normal, homogenized [OPG study]3.8025411
GSM549108patient 138, normal, homogenized [OPG study]3.9091413
GSM549119patient 077, normal, homogenized [OPG study]3.9946716
GSM549133patient 032, cancer, homogenized [OPG study]3.8290112
GSM549139patient 042, cancer, homogenized [OPG study]4.2416823
GSM549099patient 107, normal, homogenized [OPG study]4.2003821
GSM549109patient 139, normal, homogenized [OPG study]3.9592714
GSM549110patient 046, normal, homogenized [OPG study]3.9063713
GSM549114patient 063, normal, homogenized [OPG study]3.8206612
GSM549122patient 082, normal, homogenized [OPG study]3.95615
GSM549134patient 033, cancer, homogenized [OPG study]3.9172314
GSM549136patient 036, cancer, homogenized [OPG study]4.0246718
GSM549140patient 044, cancer, homogenized [OPG study]4.0790819
GSM549111patient 047, normal, homogenized [OPG study]3.7998211
GSM549113patient 057, normal, homogenized [OPG study]3.7858911
GSM549132patient 031, cancer, homogenized [OPG study]3.8834813
GSM549137patient 038, cancer, homogenized [OPG study]3.8251811
GSM549142patient 047, cancer, homogenized [OPG study]4.081316
GSM549100patient 110, normal, homogenized [OPG study]3.938114
GSM549107patient 135, normal, homogenized [OPG study]3.895514
GSM549115patient 068, normal, homogenized [OPG study]3.7417810
GSM549116patient 072, normal, homogenized [OPG study]3.71858
GSM549120patient 078, normal, homogenized [OPG study]3.7580410
GSM549131patient 030, cancer, homogenized [OPG study]4.0307818
GSM549118patient 074, normal, homogenized [OPG study]4.0299617
GSM549129patient 027, cancer, homogenized [OPG study]4.0788218
GSM549123patient 088, normal, homogenized [OPG study]4.2427123
GSM549124patient 006, cancer, homogenized [OPG study]3.9955615
GSM549126patient 015, cancer, homogenized [OPG study]4.0562218
GSM549128patient 025, cancer, homogenized [OPG study]3.9682816
GSM549103patient 117, normal, homogenized [OPG study]3.8826912
GSM549117patient 073, normal, homogenized [OPG study]3.8769713
GSM549138patient 041, cancer, homogenized [OPG study]3.7658910
GSM549141patient 045, cancer, homogenized [OPG study]4.1344821
GSM549130patient 028, cancer, homogenized [OPG study]3.8604612
GSM549101patient 111, normal, homogenized [OPG study]3.927814
GSM549105patient 128, normal, homogenized [OPG study]3.7822110
GSM549106patient 134, normal, homogenized [OPG study]3.8984715
GSM549112patient 048, normal, homogenized [OPG study]3.8709213
GSM549125patient 011, cancer, homogenized [OPG study]3.627066
GSM549127patient 024, cancer, homogenized [OPG study]4.081819
GSM549135patient 035, cancer, homogenized [OPG study]4.0908220